Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Penumbra Q3 2026 Results: Net Income $42.3M, Down 7.8% YoY

Penumbra Inc. reported revenue of $410.1 million for the third quarter of 2026, a 15.6% increase year-over-year, though net income decreased slightly to $42.3 million from $45.9 million due to higher operating expenses and a significantly higher tax provision. For the first nine months of 2026, the company generated $174.6 million in operating cash flow and maintained a strong liquidity position with $673.6 million in cash and marketable investments.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue410.1354.7
Gross profit280.3240.4
Profit before tax56.352.3
Net income42.345.9
EPS (diluted, $ a share)$1.07$1.17

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-7.8%
Revenue, year on year+15.6%
Gross margin68.3%
Operating margin12.4%
Source

10-Q filed with the SEC, NYSE: PEN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Penumbra Inc: key numbers

Share price
$320.62Close, Nov 16
Market cap
$12.6B
Shares outstanding
39.41MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Penumbra Inc

All →
4:15 PM ET 8-K
Financial Results

Penumbra Financial Results

Penumbra reported third quarter 2026 revenue of $410.1 million, a 15.6% increase year-over-year, driven by strong growth in its global thrombectomy business. The company reported net income of $42.3 million but noted it will not provide future guidance due to its pending acquisition by Boston Scientific Corporation. Operating expenses for the quarter included $7.1 million in acquisition-related costs.

Counterparty
Boston Scientific Corporation

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.